Keith A. Goldan

Chief Financial Officer

Chief Financial Officer at Syndax Pharmaceuticals Inc, filing insider transactions between 2026-02-06 and 2026-02-09.

Total Purchases

—

0 transactions

Total Sales

$115K

2 transactions

Companies Traded

2 total filings

Active Since

2026-02-06

Last: 2026-02-09

Companies

Syndax Pharmaceuticals Inc

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-09	SNDX	Sale	3,410	$21.03	$72K	140.4K	SEC ↗
2026-02-06	SNDX	Sale	2,082	$20.62	$43K	143.8K	SEC ↗